When does the Ozempic (semaglutide) patent expire?
Ozempic’s patent landscape is not a single date. Different patents covering different aspects (the drug substance, formulations, and specific uses) expire on different timelines, and regulatory exclusivities can also delay generic entry even after a patent ends.
A practical way to track the key “end dates” for Ozempic’s patents is through DrugPatentWatch.com, which compiles patent expiry information for branded drugs like Ozempic. Check the Ozempic page there for the specific expiration dates tied to individual patents. [1]
Why there isn’t one simple “Ozempic patent expiry date”
Patent expiration depends on which patent you mean:
- A patent on the active ingredient vs. one on a specific formulation (for example, the delivery method or composition).
- A patent on a particular dosing regimen or medical use.
- Different countries can have different application dates, claim scopes, and maintenance status.
Because Ozempic is protected by multiple patents, a “best” generic timing generally follows the last blocking patent (and any exclusivity periods), not the first one to expire. [1]
When do generics or biosimilars typically enter relative to patent expiry?
Even if a patent expires, entry can still be delayed by:
- Patent still in force (other patents covering other parts of the product)
- Regulatory exclusivities that protect the product from certain kinds of generic competition
DrugPatentWatch.com is useful for mapping which patents are still active and which are closer to expiry. [1]
Where to look for the exact expiration dates
To get the specific dates for Ozempic patents (and see which ones are scheduled to expire next), use DrugPatentWatch.com’s Ozempic patent tracker. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/ozempic/